<DOC>
	<DOCNO>NCT02163434</DOCNO>
	<brief_summary>The investigator compare effectiveness gabapentin metoclopramide 1-2 week among 80 woman hyperemesis gravidarum ( HG ) randomize , double-blinded trial . After completion 2-week double-blind phase , subject offer open-label gabapentin rescue metoclopramide symptom longer require treatment . Enrollment occur University Buffalo University Rochester .</brief_summary>
	<brief_title>Comparison Gabapentin Metoclopramide Treating Hyperemesis Gravidarum</brief_title>
	<detailed_description />
	<mesh_term>Hyperemesis Gravidarum</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1 . Have receive least 2 administration intravenous ( iv ) hydration separate least 1 week daily emesis least last 14 day 1 administration iv hydration . 2 . Have least one following : 34+ ketonuria , serum potassium &lt; 3.4mmol , &gt; 5 % weight loss weight upon entry prenatal care . 3 . Have fail therapy least one antiemetic . 4 . Have fetal ultrasound within 6 week prior enrollment confirm normalappearing , intrauterine , singleton pregnancy gestational age &lt; 16 week time enrollment . 5 . Felt patient 's obstetrician emergency room attend physician medical problem bowel obstruction , pancreatitis , biliary colic , peptic ulcer disease could contribute patient 's symptom . 6 . Be &gt; 18 year old decide terminate pregnancy . 7 . Have receive planning receive peripherally inserted central catheter ( PIC line ) . 8 . Have MotheriskPUQE score â‰¥12 24hour Baseline period . 9 . Felt significant medical , psychiatric substance abuse problem would preclude participation study . 10 . Denies drink alcohol learn current pregnancy . 11 . Agrees discontinue current antiemetic treatment ( include antihistamine , ginger , &gt; 10mg/day vitamin B6 , serotonin dopamine antagonist , anticholinergic , acupuncture , hypnosis , wrist band ) next 4 week . 12 . Pregnancy conceive invitro fertilization . 13 . Able understand comply study procedure give inform consent . None mention Inclusion Criteria .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>pregnancy</keyword>
	<keyword>nausea</keyword>
	<keyword>vomit</keyword>
	<keyword>hyperemesis</keyword>
	<keyword>treatment</keyword>
	<keyword>gabapentin</keyword>
	<keyword>metoclopramide</keyword>
	<keyword>safety</keyword>
</DOC>